Affinity Asset Advisors »

Cogent Biosciences shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Cogent Biosciences shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 1.0M 1.18

More positions owned by Affinity Asset Advisors

Spdr Series Trust State Street Spd Put Option (XBI)
Apogee Therapeutics (APGE)
Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Ishares Tr Ishares Biotech Call Option (IBB)
Ventyx Biosciences (VTYX)
Xenon Pharmaceuticals (XENE)
Praxis Precision Medicines I Com New (PRAX)
Cytokinetics Com New (CYTK)
Amgen (AMGN)
Spyre Therapeutics Com New (SYRE)
Wave Life Sciences SHS (WVE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Select Sector Spdr Tr State Street Hea Call Option (XLV)
Roivant Sciences SHS (ROIV)

View all positions for Affinity Asset Advisors

Top funds holding Cogent Biosciences

Ing Investment Management
Wolverine Asset Management
Calamos Advisors
Lord, Abbett & Co
Jump Financial
Polar Capital Holdings
SSI Investment Management
Advent Capital Management
Wellesley Investment Advisors
Jane Street
Affinity Asset Advisors
Gabelli Funds
Goss Wealth Management

View all funds holding Cogent Biosciences